These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25956467)

  • 1. Therapeutic uses of somatostatin and its analogues: Current view and potential applications.
    Rai U; Thrimawithana TR; Valery C; Young SA
    Pharmacol Ther; 2015 Aug; 152():98-110. PubMed ID: 25956467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis.
    Dasgupta P
    Pharmacol Ther; 2004 Apr; 102(1):61-85. PubMed ID: 15056499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes.
    Boehm BO
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1501-9. PubMed ID: 12943494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of somatostatin receptor ligands in obesity and diabetic complications.
    Boehm BO; Lustig RH
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):493-509. PubMed ID: 12079271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
    Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
    Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors.
    Davis MI; Wilson SH; Grant MB
    Horm Metab Res; 2001 May; 33(5):295-9. PubMed ID: 11440276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.
    Hasskarl J; Kaufmann M; Schmid HA
    Future Oncol; 2011 Jul; 7(7):895-913. PubMed ID: 21732759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future aspects of somatostatin-receptor-mediated therapy.
    Oberg K
    Neuroendocrinology; 2004; 80 Suppl 1():57-61. PubMed ID: 15477719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future clinical prospects in somatostatin/cortistatin/somatostatin receptor field.
    Dalm VA; Hofland LJ; Lamberts SW
    Mol Cell Endocrinol; 2008 May; 286(1-2):262-77. PubMed ID: 17942217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of new potential therapeutic applications of somatostatin analogs.
    Pawlikowski M; Melen-Mucha G
    Neuro Endocrinol Lett; 2003; 24(1-2):21-7. PubMed ID: 12743527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelled somatostatin analog therapy in prostate cancer: current status and future directions.
    Liu Y
    Cancer Lett; 2006 Jul; 239(1):21-6. PubMed ID: 16126334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin: a review of its effects especially in human beings.
    Hansen AP; Lundbaek K
    Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies of somatostatin and somatostatin-analogues: therapeutic advances and perspectives.
    Moreau JP; DeFeudis FV
    Life Sci; 1987 Feb; 40(5):419-37. PubMed ID: 2880272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Somatostatin, somatostatin analogs and their clinical use].
    Krsek M
    Cas Lek Cesk; 2003 Mar; 142(3):134-8; discussion 139. PubMed ID: 12756839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.
    Rolleman EJ; Melis M; Valkema R; Boerman OC; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2010 May; 37(5):1018-31. PubMed ID: 19915842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.